share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Mar 5 17:59
Summary by Moomoo AI
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 1, 2024, Klinger acquired 233 shares through the exercise of derivative securities. Subsequently, on March 4, 2024, Klinger sold 117 shares on the open market at a price of $94.3383 per share. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 8,673 shares. The total market value of the disposed shares was approximately $11,037.58.
Moderna, Inc.'s Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 1, 2024, Klinger acquired 233 shares through the exercise of derivative securities. Subsequently, on March 4, 2024, Klinger sold 117 shares on the open market at a price of $94.3383 per share. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 8,673 shares. The total market value of the disposed shares was approximately $11,037.58.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more